Data Results

In December 2020, the Together 2 Goal® campaign released the Q3 2020 data results based on data submitted from participating groups.

All participating campaign groups received an email with their organization’s identification code to allow for blinded feedback and comparison to other participants. Based on your assigned group code, you can see your organization’s performance summary.

Measurement Period (Q3 2020): Oct 1, 2019 – Sep 30, 2020.

^*Please note that this measurement period may be impacted by disruptions to the US Health System due to COVID-19. Disruptions to individual health systems due to COVID-19 began in March 2020 and have fluctuated throughout the year based on state and local level responses to the public health crisis in their locality.

Average Prevalence Rate (Q3 2020): 15.3%
Average HbA1c Control Rate (<8%): 68.1%
Average Blood Pressure Control Rate (<140/90): 76.1 %
Average Medical Attention for Nephropathy: 88.6%
Average Lipid Management: 77.6 %
Average Bundle Measure Control: 41.1 %

Prevalence of Type 2 Diabetes Among Total Patient Population	HbA1c Control	Blood Pressure Control
Proportion of Patients with Medical Attention for Nephropathy	Proportion of Patients with Lipid Management	Proportion of Patients Compliant with All Elements of the T2G Bundle
	Distribution of Measure Performance Rate

Please contact DataHelpForT2G@amga.org with any questions about this information.

PARTICIPATING GROUPS